Cardiovascular risk factors and comorbidities in people living with HIV: A cross-sectional multicenter study from Colombia comorbidities in a Colombian PLWHIV population.


Journal

International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 4 5 2022
medline: 14 6 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

HIV is an independent risk factor for cardiovascular diseases (CVD). There is insufficient information regarding comorbidities and cardiovascular risk factors in the Colombian HIV population. The aim of this study is to describe the prevalence of cardiovascular risk factors and comorbidities in patients from the HIV Colombian Group VIHCOL. This is a multicenter, cross-sectional study conducted in the VIHCOL network in Colombia. Patients 18 years or older who had at least 6 months of follow-up were included. A stratified random sampling was performed to estimate the adjusted prevalence of cardiovascular risk factors and comorbidities. A total of 1616 patients were included. 83.2% were men, and the median age was 34 years. The adjusted prevalence for dyslipidemia, active tobacco use, hypothyroidism, and arterial hypertension was 51.2% (99% CI: 48.0%-54.4%), 7.6% (99% CI: 5.9%-9.3%), 7.4% (99% CI: 5.7%-9.1%), and 6.3% (99% CI: 4.8%-7.9%), respectively. In this Colombian HIV cohort, there is a high prevalence of modifiable CVD risk factors such as dyslipidemia and active smoking. Non-pharmacological and pharmacological measures for the prevention and management of these risk factors should be reinforced.

Identifiants

pubmed: 35502981
doi: 10.1177/09564624221089456
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-651

Auteurs

Sandra Valderrama-Beltrán (S)

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Research Group on Infectious Diseases, Hospital Universitario San Ignacio, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

Samuel Martínez-Vernaza (S)

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Research Group on Infectious Diseases, Hospital Universitario San Ignacio, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

María Figueredo (M)

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Research Group on Infectious Diseases, Hospital Universitario San Ignacio, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

Ernesto Martínez (E)

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, 28006Universidad Del Valle, Cali, Colombia.

Kevin J Blair (KJ)

Department of Surgery, David Geffen School of Medicine, 12222University of California, Los Angeles, CA, USA.
Division of Infectious Diseases, Department of Medicine, South American Program in HIV Prevention Research (SAPHIR), UCLA, Los Angeles, CA, USA.

Juliana Cuervo-Rojas (J)

Department of Clinical Epidemiology and Biostatistics, School of Medicine, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

Leonardo Arévalo (L)

HIV Clinic, Centro de Expertos para Atención Integral, Cepain, Colombia.

Alejandro De La Hoz (A)

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Research Group on Infectious Diseases, Hospital Universitario San Ignacio, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

Camilo Quiroga (C)

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Research Group on Infectious Diseases, Hospital Universitario San Ignacio, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

Héctor Mueses (H)

HIV Clinic, 456131Corporación de Lucha Contra El Sida, Cali, Colombia.

Otto Sussmann (O)

HIV Clinic, Infectoclínicos, Bogotá, Colombia.
HIV Clinic, Asistencia Científica de Alta Complejidad, Bogotá, Colombia.

Mónica Mantilla (M)

HIV Clinic, Centro de Expertos para Atención Integral, Cepain, Colombia.
HIV Clinic, SANAS IPS, Bogotá, Colombia.

Christian Ramírez (C)

HIV Clinic, SIES Salud, Bogotá, Colombia.

Claudia Gonzalez (C)

HIV Clinic, SIES Salud, Bogotá, Colombia.

Leonardo Montero-Riascos (L)

Division of Infectious Diseases, School of Medicine, 67637Universidad Libre, Cali, Colombia.
HIV Clinic, Todomed Cali, Cali, Colombia.

Monica Botero (M)

HIV Clinic, Todomed Cali, Cali, Colombia.

Juan Alzate-Ángel (J)

HIV Clinic, CIB Medellín, Medellín, Colombia.

Martha García-Garzón (M)

HIV Clinic, SIES Salud, Bogotá, Colombia.

Julieta Franco (J)

HIV Clinic, SIES Salud, Bogotá, Colombia.

William Lenis (W)

HIV Clinic, Recuperar Cali, Cali, Colombia.

Ximena Galindo-Orrego (X)

HIV Clinic, 456131Corporación de Lucha Contra El Sida, Cali, Colombia.

Javier Stand (J)

HIV Clinic, Centro de Expertos para Atención Integral, Cepain, Colombia.

Norberto Fonseca (N)

HIV Clinic, Asistencia Científica de Alta Complejidad, Bogotá, Colombia.

Diana Alzamora (D)

HIV Clinic, Vivir Bien Cartagena, Cartagena, Colombia.

Olga Ramos (O)

HIV Clinic, Centro de Expertos para Atención Integral, Cepain, Colombia.

Wilmar Tobon (W)

HIV Clinic, Centro de Expertos para Atención Integral, Cepain, Colombia.

Jaime Ruiz (J)

Research Department, MSD Colombia, Bogotá, Colombia.

Sebastián León (S)

Research Department, MSD Colombia, Bogotá, Colombia.

Monica Rojas-Rojas (M)

Research Department, MSD Colombia, Bogotá, Colombia.

Juan Urrego-Reyes (J)

Research Department, MSD Colombia, Bogotá, Colombia.

Claudia Beltrán-Rodríguez (C)

Research Department, MSD Colombia, Bogotá, Colombia.

Diego Rosselli (D)

Department of Clinical Epidemiology and Biostatistics, School of Medicine, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

Diego-Andres Rodriguez-Lugo (DA)

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Research Group on Infectious Diseases, Hospital Universitario San Ignacio, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

Lina Paola Villamil-Castañeda (LP)

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Research Group on Infectious Diseases, Hospital Universitario San Ignacio, 27964Pontificia Universidad Javeriana, Bogotá, Colombia.

Carlos Álvarez-Moreno (C)

Vicepresidente Científico, Clínica Colsanitas, Bogotá, Colombia.
Division of Infectious Diseases, Facultad de Medicina, 28021Universidad Nacional de Colombia, Bogotá, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH